Machine Learning–Based Enhanced MRI Radiomics for PDCD1 Prognostication and Expression Prediction in Breast Cancer.

Background: Programmed cell death 1 (PDCD1) is an immune checkpoint inhibitor that plays an important role in immune evasion in breast cancer (BC). In this study, we aimed to evaluate the correlation between PDCD1 expression, immune cell tumor infiltration, and prognosis. In addition, we also develo...

Descripción completa

Detalles Bibliográficos
Publicado en:Clinical Medicine Insights: Oncology Vol. 19; pp. 1 - 11
Autores principales: Gao, Yingying, Li, Zihan, Li, Ziyun, Gao, Xueyan
Formato: research tables/charts Journal Article
Publicado: Sage Publications Inc. 11/28/2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=189855970&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 189855970
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        11795549
        B3KT
      jtl: Clinical Medicine Insights: Oncology
      issn: 11795549
      maglogo: Y
    pubinfo:
      dt: 11/28/2025
      vid: 19
      pid: 344
      pub: Sage Publications Inc.
      place: Thousand Oaks, California
    artinfo:
      ui:
        189855970
        189855970
        189855970
        10.1177/11795549251399383
        189855970
      ppf: 1
      ppct: 10
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Machine Learning–Based Enhanced MRI Radiomics for PDCD1 Prognostication and Expression Prediction in Breast Cancer.
      aug:
        au:
          Gao, Yingying
          Li, Zihan
          Li, Ziyun
          Gao, Xueyan
        affil: The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, P.R. China
      sug:
        subj:
          Breast Neoplasms Familial and Genetic
          Breast Neoplasms Prognosis
          Magnetic Resonance Imaging Methods
          Radiomics
          Programmed Cell Death Protein 1 Receptor
          Gene Expression
          Prediction Models Evaluation
          Machine Learning Algorithms Evaluation
          Tumor Markers, Biological
          Human
          Breast Neoplasms Immunology
          Neoplasm Invasiveness
          Survival Analysis
          Overall Survival
          Validity
          Descriptive Statistics
          Confidence Intervals
          Univariate Statistics
          Signal Transduction
          Killer Cells, Natural
          Tumor Necrosis Factor
          Interleukins
          STAT Proteins
          NF-kappa B
          Interferons
          RNA
          Sequence Analysis
          Support Vector Machine
          ROC Curve
          Regression
          Calibration
          Data Analysis Software
      ab: Background: Programmed cell death 1 (PDCD1) is an immune checkpoint inhibitor that plays an important role in immune evasion in breast cancer (BC). In this study, we aimed to evaluate the correlation between PDCD1 expression, immune cell tumor infiltration, and prognosis. In addition, we also developed a predictive model to determine PDCD1 expression levels in patients with BC based on radiomics features extracted from magnetic resonance imaging (MRI). Methods: Clinical data of 1082 patients with BC extracted from The Cancer Genome Atlas (TCGA) and MRI data of 108 patients with BC extracted from The Cancer Imaging Archive (TCIA) were used to determine the correlation between PDCD1 expression levels and the prognosis, clinical stage, survival, and levels of immune cell tumor infiltration in patients with BC. Predictive radiomics features for PDCD1 were extracted by 2 physicians from MRI data. The top 5 predictive features were evaluated and selected to build 2 machine learning models. Results: The PDCD1 expression levels were significantly higher in tumor tissues from patients with BC (P <.001). High PDCD1 expression levels were associated with improved overall survival, hazard ratio (HR) = 0.63, 95% confidence interval (CI) 0.425-0.934, P =.021. The PDCD1 expression levels showed a significant positive correlation with immune cell infiltration, including CD8 (P <.001) and Treg (P <.001). Both MRI radiomics models demonstrated good accuracy, strong clinical utility, and a high level of consistency in discriminating between low and high PDCD1 expression levels (P >.05). Conclusions: PDCD1 expression showed a good correlation with prognosis and tumor immune cell infiltration. The MRI radiomics model accurately predicted PDCD1 expression levels and could potentially serve as a noninvasive tool to predict early tumor response to immunotherapy.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N